Atlas Trials

Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

Clinical trial NCT00605566 · COMPLETED

Trial details

NCT number
NCT00605566
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2008-01-01
Primary completion
2015-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.